Key result
Established cardiac biomarkers like natriuretic peptides and high-sensitivity troponins, along with emerging systemic biomarkers, are valuable for diagnosing and prognosticating acute heart failure.
Why the study?
In acute decompensated heart failure, dyspnea presenting in isolation without specific signs can hinder timely diagnosis.
Established cardiac biomarkers (natriuretic peptides, troponins) and emerging systemic biomarkers (GDF-15, exhaled acetone) play important roles in the diagnosis and prognosis of acute heart failure.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ávila et al. (2023) conducted a review in Acute Heart Failure. Biomarkers (Natriuretic Peptides, High-Sensitivity Troponins, Emerging Systemic Biomarkers) was evaluated. Established cardiac biomarkers like natriuretic peptides and high-sensitivity troponins, along with emerging systemic biomarkers, are valuable for diagnosing and prognosticating acute heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: